He called on doctors, hospital leaders and health officials to work together to stop the spread of the infections. “Our strongest antibiotics don’t work, and patients are left with potentially untreatable infections,” he said.
Although the bacteria, known as Carbapenem-Resistant Enterobacteriaceae, or CRE, haven’t spread to the wider community — like some other germs — they are more dangerous, said Frieden, who described them as a “triple threat.”
First, the bacteria are resistant to all or nearly all antibiotics, even those of last resort, he said. Second, they kill up to half of patients who get bloodstream infections from them. And third, the bacteria can transfer their antibiotic resistance to other bacteria within the family, potentially making other bacteria untreatable, as well.
For example, carbapenem-resistant Klebsiella, which caused the NIH outbreak, “can spread the genes that destroy our last antibiotics to other bacteria, such as E. coli, and make E. coli resistant to antibiotics also,” Frieden said.
E. coli is the most common cause of urinary tract infections in healthy people.
In 10 years, the percentage of Enterobacteriaceae resistant to antiobiotics increased almost fourfold, to 4.2 percent in 2011 from 1.2 percent in 2001, according to data reported to CDC. And the strain that caused the NIH outbreak has increased sevenfold in the past decade, according to a CDC report issued Tuesday.
During the first half of 2012, almost 200 hospitals and long-term acute-care facilities treated at least one patient infected with these bacteria. The CDC did not have statistics for fatalities.
Enterobacteriaceae are a family of more than 70 bacteria, including E. coli, that normally live in the digestive system. Over time, some of these bacteria have become resistant to a group of antibiotics known as carbapenems, often referred to as last-resort antibiotics. During the past decade, CDC tracked one type of CRE from a single health-care facility to facilities in at least 42 states, according to a CDC news release.
Only six states — Tennessee, Minnesota, Colorado, Wisconsin, Oregon and North Dakota — require hospitals and health-care facilities to report CRE infections to state health departments.
The NIH outbreak sickened 19 patients, including the woman who brought the germ with her when she was transferred to the Bethesda facility; 12 patients died. Seven of the deaths were directly attributed to an antibiotic-resistant strain of the bacterium Klebsiella pneumoniae.
When the outbreak erupted, the clinical center’s infection control staff scrambled, walling off infected patients and tearing out plumbing. They swabbed equipment, walls, railings and patients to track and contain the bacterium. Despite these extreme efforts, the outbreak still ticked along for more than a year as the hardy superbug lingered on hard surfaces — and inside patients, among the sickest of the sick.
The seven patients who died of bloodstream Klebsiella infections had immune systems weakened by cancer, anti-rejection drugs given after organ transplants, and genetic disorders.
Almost all CRE infections occur in patients receiving care for serious conditions in hospitals, long-term acute-care facilities (such as those providing wound care or ventilation) or nursing homes.
These patients often have catheters or ventilators, which can allow bacteria “to get deeply into a patient’s body,” Frieden said.
The germs themselves spread from person to person, often on the hands of doctors, nurses and other health-care professionals.
The CDC said the spread of the germs can be controlled with proper precautions and better practices. Standard infection control precautions include washing hands and dedicating staff, rooms and equipment to the care of patients with CRE. Prescribing antibiotics wisely can significantly reduce the problem.
Patients who are hospitalized can, and should, ask their doctors and nurses to wash their hands before touching them, the officials said. And patients should not always demand antibiotics for their illnesses.
“Not all fevers require antibiotics. The more we use antibiotics, the more we encourage the spread of antibiotic resistance,” Frieden said.